Ligand Pharmaceuticals | Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.99M 4.82M 2025-09
Arrowhead Research USD 201.64M 112.94M 2025-12
Baxter International USD 1.97B 240M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Enviri Corporation USD 115.36M 17.56M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Glaxosmithkline GBP 3.3B 303M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Insmed USD 510.44M 175.68M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
MacroGenics USD 80.13M 50.56M 2025-09
Merck USD 18.17B 10.16B 2025-09
Pacira USD 158.54M 10.96M 2025-12
Pfizer USD 1.34B 295M 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Veracyte USD 362.58M 47M 2025-12


Ligand Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.